Photothermal-driven sequential immunotherapy overcomes resistance to PARP inhibition in Brca1-deficient triple-negative breast cancer.

Xu Z, Wang S, Cao Y, Song J, Liu Y, Zhang R, Tang X, Wang Y, Wu H, Tu J, Chen Q, Sun C

DOI: 10.1016/j.apsb.2026.07.022
Published: 2026 Sep
Container: Acta pharmaceutica Sinica. B
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2026.07.022,
  title = {Photothermal-driven sequential immunotherapy overcomes resistance to PARP inhibition in Brca1-deficient triple-negative breast cancer.},
  author = {Xu Z and Wang S and Cao Y and Song J and Liu Y and Zhang R and Tang X and Wang Y and Wu H and Tu J and Chen Q and Sun C},
  year = {2026},
  journal = {Acta pharmaceutica Sinica. B},
  doi = {10.1016/j.apsb.2026.07.022},
  url = {https://doi.org/10.1016/j.apsb.2026.07.022}
}

RIS

TY  - JOUR
TI  - Photothermal-driven sequential immunotherapy overcomes resistance to PARP inhibition in Brca1-deficient triple-negative breast cancer.
AU  - Xu Z
AU  - Wang S
AU  - Cao Y
AU  - Song J
AU  - Liu Y
AU  - Zhang R
AU  - Tang X
AU  - Wang Y
AU  - Wu H
AU  - Tu J
AU  - Chen Q
AU  - Sun C
PY  - 2026
JO  - Acta pharmaceutica Sinica. B
DO  - 10.1016/j.apsb.2026.07.022
UR  - https://doi.org/10.1016/j.apsb.2026.07.022
ER  -

APA

Z, X., S, W., Y, C., J, S., Y, L., R, Z., X, T., Y, W., H, W., J, T., Q, C., & C, S. (2026). Photothermal-driven sequential immunotherapy overcomes resistance to PARP inhibition in Brca1-deficient triple-negative breast cancer.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.07.022

Source records

pubmed · retrieved 2026-09-25T05:44:27.011Z